Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006515
Filing Date
2022-06-13
Accepted
2022-06-13 19:02:58
Documents
1
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 form4-06132022_040646.html 4  
1 form4-06132022_040646.xml 4 3985
  Complete submission text file 0001415889-22-006515.txt   5458
Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Kulkarni Samarth (Reporting) CIK: 0001682019 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221013025

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)